Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi

ÖZKAN, Suavi; BÜYÜKDOĞAN, Murat

Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi

Suavi ÖZKAN, (Adana Numune Eğitim ve Araştırma Hastanesi, Genel Cerrahi Kliniği, Adana, Türkiye)

Murat BÜYÜKDOĞAN (Selçuk Üniversitesi, Meram Tıp Fakültesi, Genetik Hastalıklar Tanı Merkezi, Konya, Türkiye)

Tıp Araştırmaları Dergisi

3 1

Yıl: 2010 Cilt: 8 Sayı: 1 Sayfa Aralığı: 9 - 14 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi

Öz:

Kadınlarda meme kanseri akciğer ve kolorektal kanserlerden sonra 3. en sık ölüm nedenidir. Çalışmamızın amacı, Adana Numune Hastanesi Genel Cerrahi Kliniğinde Ocak 1997 – Aralık 2003 tarihleri arasında ameliyat edilen meme kanserli kadın hastaların retrospektif dosya kayıtlarının incelenmesinde, sağ kalım üzerinde etkili olan yaş, tümörün evresi, çapı, histolojik tipi, uygulanan ameliyat tipi, metastatik aksiller lenf nodlarının sayısı ile radyo/kemoterapi gibi prognostik faktörleri belirlemektir.

Anahtar Kelime:

Konular: Onkoloji

Prognostic factors and retrospective analysis of our cases with breast cancer

Öz:

Breast cancer is the 3rd cause of death in women among worldwide following lung and colon cancers. In this retrospective review of the charts, 56 patients operated forbreastcancerin GeneralSurgery Training Clinic of Adana Numune Hospital between January 1997 and December 2003. We aimed to analyse the prognostic factors including the age, tumor grade and stage, histopathologic type , performed surgical procedures, number of excised lymph nodes and radio / chemotherapy.

Anahtar Kelime:

Konular: Onkoloji

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Spratt JS, Donegan WL, Sigdestad CP. Epidemiology and etiology.In Donegan WL ,Spratt JS,eds. Cancer of the breast. Philadelphia : WB Saunders, 1995: 116-141.
2. The Breast-Comprehensive Management of Benign and Malignant Disorder, 3rd EditionKirby I. Bland and Edward M. Copeland III, Eds., Philadelphia, PA: Saunders, an imprint of Elsevier Science, 2003, vol. 1: 842 pages, 456; vol. 2: 784
3. Winchester DP. Breast cancer in young women. In Lopez MJ,ed. Special problems in breast cancer therapy. The Surgical Clinics of North America. Philadelphia: WB Saunders 1996; 76(2): 279-287.
4. Crowe JP, Gordon NH, Shenk PR,et al. Age does not predict breast cancer outcome. Arch Surg 1994;129:483-488.
5. Caleffi M, Fentiman IS, Birkhead BG. Factors at presentation influencing the prognosis in breast cancer. Eur J Cancer Clin Oncol 1989; 25:51-56.
6. Cuttler SJ, Black MM, Mork T, et al. Further observations on prognostic factors in cancer of the female breast. Cancer 1969; 24: 653-657.
7. Williams MR, Hinton CP, Todd JH, et al. The prediction of local and regional recurrence after simple mastectomy for operable breast cancer. Br J Surg 1985; 72:721-723.
8. Veronese SM, et al. Proliferation index as a prognostic marker in breast cancer. Cancer 1993; 71: 3926-3931.
9. Locker AP, Horrocks C, Gilmour AS,et al. Flow cytometric and histological analysis of ductal carcinoma in situ of the breast. Br J Surg 1990; 77: 564-567.
10. Hastrich DJ, et al. Comparison of radioligant assay and immunostaining for epidermal growth factor receptor in human breast cancer. Br J Surg 1994; 81: 853-855.
11. Pujol P, et al. A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol. Cancer 1993; 71: 2006-2012.
12. Isola JJ, et al. Elevated c-erB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer. Cancer 1994; 73: 652-658.
13. Peyrat JP, et al. Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer. Lancet 1995; 345: 621-622.
14. Lauria L,et al. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer 1995 ; 76: 1772-1778.
15. Gaffney EV,et al. Relationship between low estrogen receptor values and other prognostic factors in primary breast tumors. Surgery 1995 ; 117: 241-246.
16. Langlands AO, Prescott RJ, Hamilton T. A clinical trial in the management of operable cancer of the breast. Br J Surg 1980; 67: 170-174.
17. Silverstein MJ, Barth A, Poller DN, et al. Ten years results comparing mastectomy to excision and radiation therapy for ductal carsinoma in situ of the breast. Eur J Cancer 1995; 31(9) : 1425-1427.
18. Wilson RE, Donegan W, Mettlin C, et al. The 1982 National survey of carsinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Oncol 1984 ; 159(4) : 309-317.
19. Nemoto T, Vana J, Bedwani RN, et al. Management and survival of female breast cancer. Cancer 1980 ; 45: 2917-1924.
20. Fischer B, Redmond C, Fischer ER, et al. Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. New Eng J Med 1985; 312 : 674-681.
21. Gaglia P, Bussone R, Cardarola B, et al. The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. Eur J Cancer Clin Oncol 1987; 23: 849-584.
22. Hacene K, Le Doussal V, Rouesse J,et al. Predicting distant metastases in operable breast cancer patients. Cancer 1990; 66: 2034-2043.
23. Erhan Y. Meme kanserlerinde prognostik faktörler. Ulusal Cerrahi Dergisi 1995; 11(5): 322-333.
24. Veronesi U, Salvadori B, Luini A,et al. Conservative treatment of early breast cancer. Ann Surg 1990; 211: 250-259.
25. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. Histopathology 1991; 19:403-410.
26. Maddox WA, Carpenter JT, Laws HT,et al. Does radical mastectomy still have a place in the treatment of primary operable breast cancer. Arch Surg 1987; 122: 1317-1320.
27. Maddox WA, Carpenter JT, Laws HT,et al. A randomize prospective trial of radical mastectomy versus modified radical mastectomy in 311 breast cancer patients. Ann Surg 1983; 198(2): 207-212.
28. Vinton LV, Traverso LW, Jolly PC. Wound complications after modified radical mastectomy compared with tylectomy with axillary node dissection. Am J Surg 1991; 161: 584-588.
29. Martin JK, van Heerden JA, Taylor WF,et al. Is modified radical mastectomy really equivalent to radical mastectomy in treatment of carcinoma of the breast.Cancer 1986; 57:510-518.
30. Rosen PP, Goshen S, Saigo PE, et al. A longterm follow-up survival in Stage I and Stage II breast carsinoma. J Clin Oncol 1989; 7:355-356.
31. Lindlay R, Bulman A, Parson P,et al. Histologic features productive of an increased risk of early local recurrence after treatment of breast cancer by local tumor excision and radical radiotherapy. Surgery 1989; 105: 13-20.
32. Cady B. Cost-effective preoperative evaluation, operative treatment, and postoperative follow-up in the breast cancer patient. In Rossi RL, Cady B,eds.Cost effectiveness in surgery. The Surgical Clinics of North America. Philadelphia : WB Saunders 1996 ; 76(1) : p25-34.
33. Styblo TM, Wood WC. Adjuvant chemotherapy in node-negative breast cancer patient. In Lopez MJ,ed. Special problems in breast cancer therapy. The Surgical Clinics of North America. Philadeplhia: WB Saunders 1996; 76(2): p327-342.
34. Wilson FJ, Cox JD. Definitive, adjuvant, palliative radiation therapy in mammary cancer. In Donegan WL ,Spratt JS,eds. Cancer of the breast. Philadelphia : WB Saunders, 1995: p505-518.
35. Seeger J, Woodcock TM. Chemotherapy for the breast cancer. In Donegan WL ,Spratt JS,eds. Cancer of the breast. Philadelphia : WB Saunders, 1995: p519-528.
36. Stierer M, Rosen HR, Weber R, et al.Longterm analysis of factors influencing the outcome in carcinoma of the breast smaller than one centimeter. Surg Gynecol Oncol 1992 ; 175 : 151-160.

APA	ÖZKAN S, BÜYÜKDOĞAN M (2010). Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi. , 9 - 14.
Chicago	ÖZKAN Suavi,BÜYÜKDOĞAN Murat Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi. (2010): 9 - 14.
MLA	ÖZKAN Suavi,BÜYÜKDOĞAN Murat Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi. , 2010, ss.9 - 14.
AMA	ÖZKAN S,BÜYÜKDOĞAN M Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi. . 2010; 9 - 14.
Vancouver	ÖZKAN S,BÜYÜKDOĞAN M Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi. . 2010; 9 - 14.
IEEE	ÖZKAN S,BÜYÜKDOĞAN M "Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi." , ss.9 - 14, 2010.
ISNAD	ÖZKAN, Suavi - BÜYÜKDOĞAN, Murat. "Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi". (2010), 9-14.

APA	ÖZKAN S, BÜYÜKDOĞAN M (2010). Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi. Tıp Araştırmaları Dergisi, 8(1), 9 - 14.
Chicago	ÖZKAN Suavi,BÜYÜKDOĞAN Murat Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi. Tıp Araştırmaları Dergisi 8, no.1 (2010): 9 - 14.
MLA	ÖZKAN Suavi,BÜYÜKDOĞAN Murat Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi. Tıp Araştırmaları Dergisi, vol.8, no.1, 2010, ss.9 - 14.
AMA	ÖZKAN S,BÜYÜKDOĞAN M Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi. Tıp Araştırmaları Dergisi. 2010; 8(1): 9 - 14.
Vancouver	ÖZKAN S,BÜYÜKDOĞAN M Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi. Tıp Araştırmaları Dergisi. 2010; 8(1): 9 - 14.
IEEE	ÖZKAN S,BÜYÜKDOĞAN M "Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi." Tıp Araştırmaları Dergisi, 8, ss.9 - 14, 2010.
ISNAD	ÖZKAN, Suavi - BÜYÜKDOĞAN, Murat. "Meme kanserinde prognostik faktörler: Vakalarımızın retrospektik analizi". Tıp Araştırmaları Dergisi 8/1 (2010), 9-14.